APhA Policy Manual

Gluten Content and Labeling in Medications

EDUCATION, CURRICULUM AND COMPETENCE FOR PHARMACY LABELING RESEARCH

APhA supports labeling of all prescription and nonprescription products, as well as dietary supplement products, to indicate the presence of gluten.
APhA encourages manufacturers to formulate drug products without use of wheat, barley, rye, or their derivatives whenever possible.
APhA supports additional research on the effects of gluten intolerance and celiac malabsorption, particularly as it relates to medication absorption.
APhA supports pharmacist education regarding celiac disease and non-celiac gluten sensitivity.
APhA encourages the development of analytical methods that can accurately detect lower levels of gluten than the current standard (20 ppm) and for the establishment of evidence-based gluten-free standards for the labeling of foods, excipients, dietary supplements, and prescription and nonprescription products.